Healthcare

Faron Pharmaceuticals (AIM:FARN) Strategic Funding and Clinical Prog...

Faron Pharmaceuticals (AIM:FARN) Strategic Funding and Clinical Progress in Cancer Immunotherapy

AstraZeneca (LSE:AZN) Navigating Regulatory Challenges and Strategic...

AstraZeneca (LSE:AZN) Navigating Regulatory Challenges and Strategic Growth in Pharma

AstraZeneca Reports 21% Revenue Growth in FY24, Driven by 19% Rise i...

Highlights,Revenue Surge:,AstraZeneca’s total revenue rose by,21%,to,$54.1 billion,, led by,19% growth in product sales,and continued momentum in part...

STERIS (NYSE:STE) Sees 42% Growth Over Five Years Despite Recent Dec...

Highlights,Share Price Rises Over Five Years,STERIS (STE) recorded a 42% increase over the past five years, reflecting steady growth.,Recent Performan...

Oxford BioDynamics (AIM: OBD) Announces Breakthrough Colorectal Canc...

Highlights,EpiSwitch® 3D genomics platform demonstrates 81% accuracy for early-stage CRC detection.,Non-cancerous polyps identified with 82% accuracy...

Bioventix (LON:BVXP) Stock Drops Below Two-Hundred-Day Moving Averag...

Bioventix (BVXP) saw its stock price dip below the two-hundred-day moving average.,The stock traded as low as GBX 3,051, signaling a shift in its pric...

RUA Life Sciences Delivers Positive Performance from ABISS French Su...

Highlights:,Revenue Growth:,ABISS achieved €2.3 million in revenue for the year to December 2024, marking a 7% increase over 2023.,Profit Turnaround:,...

Alliance Pharma Reports Stable Revenues in 2024 Trading Update

Highlights,Total revenues for 2024 reached £180.3 million, marking a 1% YoY decline but a 1% increase at constant exchange rates (CER).,Consumer healt...

CSL Limited (ASX:CSL) Analyzing 5-Year Earnings Growth Amidst Share...

Highlights,CSL’s share price dropped 13% over five years despite steady earnings growth.,The company's earnings per share (EPS) increased by 5.2% annu...

CVS Group Reports 6.6% Increase in Sales for H1 2025 Amid Market Cha...

Highlights,Sales Growth:,Group sales up 6.6%, totaling £341.8m for H1 2025.,Adjusted EBITDA:,Increased by 4.5% to £67.4m, with an EBITDA margin of 19....

hVIVO Acquires Two Clinical Research Units in €10M Deal to Expand Eu...

Highlights,hVIVO acquires two German clinical research units,from CRS for,€10 million,in cash.,Expands services to include Phase I and II trials,acros...

ImmuPharma (LON:IMM) Trading Up 9.3%: Positive Movement in Specialty...

Highlights,ImmuPharma's (IMM) share price surged by 9.3% on Saturday.,The company saw significant trading volume with a 60% increase from average dail...

Hikma Pharmaceuticals (LON:HIK) Hits New 52-Week High Amid Positive...

Highlights,Hikma Pharmaceuticals reaches a new 52-week high, signaling strong market performance.,Stock shows impressive growth with a significant inc...

hVIVO Secures £2.7m Laboratory Services Contract, Marking Largest St...

Highlight,Major Contract Win:,hLAB signs a £2.7m contract for a Phase 2 influenza drug trial, bringing the project's total value to £3.2m.,Internation...

Creo Medical Group PLC (LON:CREO) Insider Purchase Reflects Confiden...

Highlights,Christopher Paul Hancock acquired 4,712 shares of Creo Medical Group (CREO).,The stock opened lower on Tuesday, reflecting a slight market...

ImmuPharma (LON:IMM) Sees 27.6% Surge – What’s Driving the Momentum?

Highlights,ImmuPharma's (IMM) shares surged by 27.6% during recent trading.,Stock reached a high of GBX 3.60 before closing at GBX 3.35.,Market capita...

ImmuPharma (LON:IMM) Climbs 27.6% Amid Renewed Focus on Therapeutic...

Highlights,ImmuPharma shares surged 27.6% during recent trading, reaching an intraday high of GBX 3.60.,Trading volume saw a 61% decline from the aver...

ImmuPharma (LON:IMM) Experiences Notable Stock Surge of 27.6%

Highlights,ImmuPharma (IMM) shares surged by 27.6% during Saturday's trading session.,Stock peaked at GBX 3.60, closing at GBX 3.35, marking a signifi...

ImmuPharma (LON:IMM) Rises 27.6% Amid Renewed Market Interest

Highlights,ImmuPharma shares climbed 27.6% during recent trading, reaching GBX 3.60 at their peak.,Trading volume declined 61% compared to the average...

ImmuPharma (LON:IMM) Sees 27.6% Rise in Stock Price

Highlights,ImmuPharma (IMM) stock price surged 27.6% on Saturday.,Trading volume reached 8,992,934 shares, marking a 61% decrease from the average.,Th...